Ontogeny of the striatal neurons expressing the D2 dopamine receptor in humans: An in situ hybridization and receptor-binding study

Molecular Brain Research

Volumn 48, Issue 2, 1997, Pages 389-400

  Brana, C ^a   Aubert, I ^a   Charron, G ^a   Pellevoisin, C ^b   Bloch, B ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSERM   (France)

Author keywords

D2 receptor; Human fetal brain; Hybridization, in situ; Receptor autoradiography; Striatal development

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; ENKEPHALIN; MESSENGER RNA;

ARTICLE; AUTORADIOGRAPHY; BINDING SITE; BIRTH; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; FETUS; FETUS DEVELOPMENT; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; NEWBORN; ONTOGENY; PRIORITY JOURNAL; PUTAMEN; RECEPTOR BINDING;

CORPUS STRIATUM; EMBRYONIC AND FETAL DEVELOPMENT; ENKEPHALINS; FEMALE; HUMANS; IN SITU HYBRIDIZATION; MALE; NEURONS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RNA, MESSENGER;

RODENTIA;

EID: 0030805164     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00114-9     Document Type: Article

References (46)

1. Aubert I., Brana C., Pellevoisin C., Giros B., Caillé I., Carles D., Vital C., Bloch B. Molecular anatomy of the development of the human substantia nigra. J. Comp. Neurol. 378:1997;2-17.
2. Balk J.-H., Picetti R., Salardi A., Thiriet G., Dierich A., Depaulis A., Le Meur M., Borrelli E. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature. 377:1995;424-428.
3. 2 receptors in the human ventral striatum. Neurosci. Lett. 150:1993;75-79.
4. Bernard V., Le Moine C., Bloch B. Striatal neurons express increased level of dopamine D2 receptor mRNA in response to haloperidol treatment: a quantitative in situ hybridization study. Neuroscience. 45:1991;117-126.
5. 1 dopamine receptors in the basal ganglia of the cat and primate: delineation of striosomal compartments and pallidal and nigral subdivisions. Neuroscience. 26:1988;101-119.
6. Brana C., Charron G., Aubert I., Carles D., Martin-Negrier M.L., Trouette H., Fournier M.C., Vital C., Bloch B. Ontogeny of the striatal neurons expressing neuropeptide genes in the human fetus and neonate. J. Comp. Neurol. 360:1995;488-505.
7. Brana C., Caillé I., Pellevoisin C., Charron G., Aubert I., Caron M.G., Carles D., Vital C., Bloch B. Ontogeny of the striatal neurons expressing the D1 dopamine receptor in humans. J. Comp. Neurol. 370:1996;23-34.
8. Brené S., Herrera-Marschitz M., Persson H., Lindefors N. Expression of mRNAs encoding dopamine receptors in striatal regions is differentially regulated by midbrain and hippocampal neurons. Mol. Brain Res. 21:1994;274-282.
9. Chen J.F., Qin Z.H., Szele F., Bai G., Weiss B. Neuronal localization and modulation of the D2 dopamine receptor mRNA in brain of normal mice and mice lesioned with 6-hydroxydopamine. Neuropharmacology. 30:1991;927-941.
10. Chen J.F., Weiss B. Ontogenic expression of dopamine receptor mRNA in rat corpus striatum. Dev. Brain Res. 63:1991;95-104.
11. 3H]YM-09151-2. Eur. J. Pharmacol. 199:1991;103-106.
12. Dearry A., Gingrich J.A., Falardeau P., Fremeau R.T., Bates M.D., Caron M.G. Molecular cloning and expression of the gene for a human D1 dopamine receptor. Nature. 347:1990;72-76.
13. A. Feess-Higgins and J.C. Larroche, Le Développement du Cerveau Foetal Humain. Atlas Anatomique, INSERM-CNRS, Masson, Paris, France, 1987.
14. Freeman T.B., Spence M.S., Boss B.D., Spector D.H., Strecker R.E., Olano C.W., Kordower J.H. Development of dopaminergic neurons in the human substantia nigra. Exp. Neurol. 113:1991;344-353.
15. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J. Jr., Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
16. Gerfen C.R., McGinty J.F., Young W.S. III Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J. Neurosci. 11:1991;1016-1031.
17. Grandy D.K., Marcionni M.A., Makam H., Stofko R.E., Alfano M., Frothingham L., Fisher J.B., Burke-Howie K.J., Bunzow J.R., Server A.C., Civelli O. Cloning of the cDNA and gene for a human D2 dopamine receptor. Proc. Natl. Acad. Sci. USA. 86:1989;9762-9766.
18. Graybiel A.M. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13:1990;244-254.
19. 3H]nemonapride. Eur. J. Pharmacol. 301:1996;R1-R3.
20. Helmeste D., Tang S.W., Bunney W.E. Jr., Potkin S.G., Jones E.G. Decrease in σ but no increase in striatal dopamine D4 sites in schizophrenic brains. Eur. J. Pharmacol. 314:1996;R3-R5.
21. Huntley G.W., Morrison J.H., Prikhozhan A., Sealfon S.C. Localization of multiple dopamine receptor subtype mRNAs in human and monkey motor cortex and striatum. Mol. Brain Res. 15:1992;181-188.
22. Joyce J.N., Sapp D.W., Marshall J.F. Human striatal dopamine receptors are organized in compartments. Proc. Natl. Acad. Sci. USA. 83:1986;8002-8006.
23. Le Moine C., Tison F., Bloch B. D2 dopamine receptor gene expression by cholinergic neurons in the rat striatum. Neurosci. Lett. 117:1990;248-252.
24. Le Moine C., Normand E., Guitteny A.F., Fouque B., Teoule R., Bloch B. Dopamine receptor gene expression by enkephalin neurons in rat forebrain. Proc. Natl. Acad. Sci. USA. 87:1990;230-234.
25. 1 dopamine receptor gene. Proc. Natl. Acad. Sci. USA. 88:1991;4205-4209.
26. Le Moine C., Bloch B. D1 and D2 dopamine gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct efferent neuronal populations of the dorsal and ventral striatum. J. Comp. Neurol. 355:1995;418-426.
27. Lindvall O., Widner H., Rehncrona S., Brundin P., Odin P., Gustavii B., Frackowiak R., Leenders K.L., Sawle G., Rothweel J.C., Björklund A., Marsden C.D. Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants. Ann. Neurol. 31:1992;155-165.
28. Loopuijt L.D., Sebens J.B., Korf J.A. Mosaic-like distribution of dopamine receptors in rat neostriatum and its relationship to striosomes. Brain Res. 405:1987;405-408.
29. Lowenstein P.R., Slesinger P.A., Singer H.S., Walker L.C., Casanova M.F., Raskin L.S., Price D.L., Coyle J.T. Compartment-specific changes in the density of choline and dopamine uptake sites and muscarinic and dopaminergic receptors during the development of the baboon striatum: a quantitative receptor autoradiographic study. J. Comp. Neurol. 288:1989;428-446.
30. Mackenzie R.G., Zigmond M.J. Chronic neuroleptic treatment increases D2 but not D1 receptors in rat striatum. Eur. J. Pharmacol. 113:1985;159-165.
31. Mengod G., Villaro M.T., Niznik H.B., Sunahara R.K., Seeman P., O'Dowd B.F., Palacios J.M. Visualization of a dopamine D1 receptor mRNA in human and rat. Mol. Brain Res. 10:1991;185-191.
32. Mengod G., Villaro M.T., Landwehrmeyer G.B., Martinez-Mir M.I., Niznik H.B., Sunahara R.K., Seeman P., O'Dowd B.F., Probst A., Palacios J.M. Visualization of dopamine D1, D2 and D2 receptor mRNAs in human and rat brain. Neurochem. Int. 20:1992;33S-43S.
33. Murrin L.C., Gibbens D.L., Ferrer J.R. Ontogeny of dopamine, serotonin and spirodecanone receptors in rat forebrain: an autoradiographic study. Dev. Brain Res. 23:1985;91-109.
34. Nisenbaum L.K., Kital S.T., Crowley W.R., Gerfen C.R. Temporal dissociation between changes in striatal enkephalin and substance P messenger RNAs following striatal dopamine depletion. Neuroscience. 60:1994;927-937.
35. 3H]-spiperone binding: regulation of sodium and guanine nucleotides in rats. J. Neurochem. 38:1982;902-908.
36. Onali P., Olianas M., Gessa G. Characterization of dopamine receptors mediating inhibition of adenylate cyclase in rat striatum. Mol. Pharmacol. 28:1985;138-145.
37. Peschanski M., Defer G., N'Guyen J.P., Ricolfi F., Monfort J.C., Remy P., Geny C., Samson Y., Hantraye P., Jeny R., Gaston A., Keravel Y., Degos J.D., Cesaro P. Bilateral motor improvement and alteration of L-DOPA effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain. 117:1994;487-499.
38. Pollack A.E., Wooten G.F. D2 dopaminergic regulation of striatal preproenkephalin mRNA levels is mediated at least in part through cholinergic interneurons. Mol. Brain Res. 13:1992;35-41.
39. Rao P.A., Molinoff P.B., Joyce J.N. Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study. Dev. Brain Res. 60:1991;161-177.
40. 3H]spiperone binding sites in striatum. Neurochem. Int. 20:1992;559-566.
41. Richfield E.K., Young A.M., Penney J.B. Comparative distribution of dopamine D-1 and D-2 receptors in the basal ganglia of turtles, pigeons, rats, cats, and monkeys. J. Comp. Neurol. 262:1987;446-463.
42. Rosen H., Douglass J., Herbert E. Isolation and characterization of the rat proenkephalin gene. J. Biol. Chem. 259:1984;14309-14313.
43. 2 dopamine receptor subtypes in rat brain using in situ hybridization and receptor binding. Neuroscience. 62:1994;65-85.
44. Seeman P., Lee T., Chang-Wong M., Wong K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature. 261:1976;717-719.
45. Verney C., Zecevic N., Nikolic B., Alvarez C., Berger B. Early evidence of catecholaminergic cell groups in 5- and 6-week-old human embryos using tyrosine hydroxylase and dopamine-β-hydroxylase immunocytochemistry. Neurosci. Lett. 131:1991;121-124.
46. Zecevic N., Verney C. Development of the catecholamine neurons in human embryos and fetuses, with special emphasis on the innervation of the cerebral cortex. J. Comp. Neurol. 351:1995;509-535.